Cargando…
Botulinum toxin type A in the management of headache: a review of the literature and personal experience
Botulinum toxin type A (BoNT-A) shows significant promise in the management of a variety of headache types including migraine, chronic daily headache, tension-type headache, and other head and neck pains. Confirmation of efficacy still awaits the report of well-controlled double-blind placebo-contro...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452148/ http://dx.doi.org/10.1007/s10194-004-0063-z |
_version_ | 1782244440959614976 |
---|---|
author | Troost, B. Todd |
author_facet | Troost, B. Todd |
author_sort | Troost, B. Todd |
collection | PubMed |
description | Botulinum toxin type A (BoNT-A) shows significant promise in the management of a variety of headache types including migraine, chronic daily headache, tension-type headache, and other head and neck pains. Confirmation of efficacy still awaits the report of well-controlled double-blind placebo-controlled trials; however, a mounting body of evidence suggests that BoNT-A is effective, well-tolerated and safe for the management of many headache disorders. In this paper, I review recent evidence on the efficacy of BoNT-A, and also report my personal experience with the treatment in over 600 headache patients. |
format | Online Article Text |
id | pubmed-3452148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-34521482012-11-29 Botulinum toxin type A in the management of headache: a review of the literature and personal experience Troost, B. Todd J Headache Pain Review Botulinum toxin type A (BoNT-A) shows significant promise in the management of a variety of headache types including migraine, chronic daily headache, tension-type headache, and other head and neck pains. Confirmation of efficacy still awaits the report of well-controlled double-blind placebo-controlled trials; however, a mounting body of evidence suggests that BoNT-A is effective, well-tolerated and safe for the management of many headache disorders. In this paper, I review recent evidence on the efficacy of BoNT-A, and also report my personal experience with the treatment in over 600 headache patients. Springer-Verlag 2004-04 /pmc/articles/PMC3452148/ http://dx.doi.org/10.1007/s10194-004-0063-z Text en © Springer-Verlag Italia 2004 |
spellingShingle | Review Troost, B. Todd Botulinum toxin type A in the management of headache: a review of the literature and personal experience |
title | Botulinum toxin type A in the
management of headache: a review of the literature and personal
experience |
title_full | Botulinum toxin type A in the
management of headache: a review of the literature and personal
experience |
title_fullStr | Botulinum toxin type A in the
management of headache: a review of the literature and personal
experience |
title_full_unstemmed | Botulinum toxin type A in the
management of headache: a review of the literature and personal
experience |
title_short | Botulinum toxin type A in the
management of headache: a review of the literature and personal
experience |
title_sort | botulinum toxin type a in the
management of headache: a review of the literature and personal
experience |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452148/ http://dx.doi.org/10.1007/s10194-004-0063-z |
work_keys_str_mv | AT troostbtodd botulinumtoxintypeainthemanagementofheadacheareviewoftheliteratureandpersonalexperience |